NEXT Biometrics Group ASA â€“ Subscription of shares by, and grant of share options to, primary insiders

Oslo, 19 June 2020: Reference is made to the stock exchange announcements by NEXT Biometrics Group ASA ("NEXT" or the "Company") earlier today regarding (i) the approval by the general meeting of inter alia the private placement of 25,000,000 new shares in the Company, each with a par value of NOK 1.00 (the "Private Placement"), and the grant of share options to board members, and (ii) the resolution by the Company's board of directors to issue 2,262,027 new shares to settle the underwriting commission in the Private Placement, in accordance with an authorisation granted by the general meeting. 

The following primary insiders in the Company have subscribed for shares in the Private Placement, including in connection with the underwriting commission, and have been granted share options by the general meeting:

-Aponia AS (a company controlled by the chair of the board of directors, Petter Jan Fjellstad) subscribed for 822,779 shares in the Company at a subscription price of NOK 2.00 per share. Following completion of the Private Placement and the issuance of the underwriting commission shares, Aponia AS will hold 832,779 shares in the Company. The general meeting granted Petter Jan Fjellstad 1,000,000 share options in the Company, following which he holds in total 1,030,000 share options.

-Odd Harald Hauge (board member) subscribed for 548,907 shares in the Company at a subscription price of NOK 2.00 per share. Following completion of the Private Placement and the issuance of the underwriting commission shares, Odd Harald Hauge will hold 548,907 shares in the Company. The general meeting granted Odd Harald Hauge 200,000 share options in the Company, following which he holds in total 200,000 share options. 

-Spurv Invest AS (a company controlled by board member Live Haukvik) subscribed for 100,000 shares in the Company at a subscription price of NOK 2.00 per share. Following completion of the Private Placement, Spurv Invest AS will hold 100,000 shares in the Company. The general meeting granted Live Haukvik 200,000 share options in the Company, following which she holds in total 200,000 share options.  

-Emine Lundkvist (board member) subscribed for 50,000 shares in the Company at a subscription price of NOK 2.00 per share. Following completion of the Private Placement, Emine Lundkvist will hold 79,738 shares in the Company. The general meeting granted Emine Lundkvist 200,000 share options in the Company, following which she holds in total 230,000 share options. 

The vesting of the board members' options is conditional upon the person being a member of the board of directors at the date of vesting. Any resigning board members will not lose their vested options. Vested options must be exercised within six months from the date of the end of term. Board members that are dismissed upon a resolution by the general meeting or who are not re-elected, will keep their vested options, while any unvested options will elapse.

After the above-mentioned allotment, if all conditions are met, total number of issued share options to board members is 1,660,000, while the total number of issued share options in the Company is 7,079,880.

The following primary insiders in the Company have been granted share options by the board of directors:

-Peter Heuman (CEO) has been granted 2,500,000 share options in the Company, following which he holds in total 2,720,000 share options. 

-Eirik Underthun (CFO) has been granted 1,000,000 share options in the Company, following which he holds in total 1,000,000 share options. 

With regard to the option program for board members, management and employees, in total 50% of the options vest in the third calendar quarter of 2020. The remaining 50% vest in the third calendar quarter of 2021. The date of expiry for all vested options is the date falling 36 months after the date of grant. Any options that are not exercised at, or prior to, this date will elapse.

The exercise price of the share options shall be equal to the average volume weighted market price of the Company's shares over the last five trading days prior to the date of grant, being NOK 2.49.

This information is subject to the disclosure requirements set out in section 4-2 of the Norwegian Securities Trading Act.